At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

When many women turned to Depo-Provera as a convenient birth control option, they had no idea it might carry life-altering risks. After years of injections, some began experiencing troubling symptoms ...

Teenagers recover bone loss while taking Depo-Provera once they stop using the injectable contraceptive, according to a new study from Seattle researchers. Three months ago, the Food and Drug ...

Depo-Provera, an injectable contraceptive, will come with a special warning that links prolonged use of the drug with bone density loss, the government said Wednesday. The Food and Drug Administration ...

Nov. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Pfizer have notified healthcare professionals via letter of revisions to the safety labeling for medroxyprogesterone acetate (MPA) ...